Clinical Trial Update: Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV

View source ↗

Summary

This clinical trial update compares long-term Vi antibody protection induced by Bio TCV against PQed TCV in the Indonesian population. The study is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Bio TCV
• PQed TCV

Snippet

Sponsor: PT Bio Farma | Conditions: Antibody Typhoid Vaccine | Status: NOT_YET_RECRUITING